First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

463.1m
-0.6%
Assets
Growth Rates:
1 Year
+3%
3 Years
+42%
5 Years
+85%
7 Years
+153%
10 Years
-
95m
-5%
Liabilities
Growth Rates:
1 Year
-22%
3 Years
-29%
5 Years
+18%
7 Years
+446%
10 Years
-
368.1m
+0.7%
Equity
Growth Rates:
1 Year
+12%
3 Years
+93%
5 Years
+117%
7 Years
+122%
10 Years
-

Balance Sheet Decomposition
Meridian Bioscience Inc

463.1m
Assets
95m
Liabilities
463.1m
Assets
95m
Liabilities
Current Assets 210.6m
Cash & Short-Term Investments 81.5m
Receivables 47.2m
Other Current Assets 81.9m
Non-Current Assets 252.5m
PP&E 50.7m
Intangibles 190.4m
Other Non-Current Assets 11.4m
Current Liabilities 58m
Accounts Payable 17.8m
Accrued Liabilities 25.7m
Other Current Liabilities 14.5m
Non-Current Liabilities 37.1m
Long-Term Debt 25m
Other Non-Current Liabilities 12.1m

Balance Sheet
Meridian Bioscience Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2013 Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022
Assets
Cash & Cash Equivalents
44
43
50
47
57
60
62
54
50
81
Cash
12
17
25
27
37
39
42
53
49
80
Cash Equivalents
32
26
25
20
20
20
21
1
1
1
Total Receivables
26
23
26
27
29
32
36
39
54
47
Accounts Receivables
26
23
26
27
29
32
36
39
54
47
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
35
36
36
45
42
42
40
61
77
68
Other Current Assets
9
11
7
7
6
5
7
9
13
14
Total Current Assets
114
113
119
127
134
139
145
162
193
211
PP&E Net
26
28
28
31
31
30
31
38
49
51
PP&E Gross
26
28
28
31
31
30
31
38
49
51
Accumulated Depreciation
41
44
46
49
54
56
67
73
79
79
Intangible Assets
8
8
6
30
27
23
60
83
84
74
Goodwill
23
23
22
62
55
55
89
114
115
116
Other Long-Term Assets
5
6
8
3
4
5
1
8
9
11
Other Assets
23
23
22
62
55
55
89
114
115
116
Total Assets
177
N/A
177
+0%
183
+4%
252
+37%
250
-1%
251
+1%
326
+29%
405
+25%
450
+11%
463
+3%
Liabilities
Accounts Payable
6
5
7
8
8
6
7
12
12
18
Accrued Liabilities
13
8
8
10
7
12
12
24
31
26
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
4
5
5
0
0
0
0
Other Current Liabilities
1
1
1
2
3
0
2
17
4
14
Total Current Liabilities
20
14
15
23
23
24
21
53
47
58
Long-Term Debt
0
0
0
55
50
45
76
69
60
25
Deferred Income Tax
0
0
0
3
5
4
3
4
1
1
Other Liabilities
2
2
2
5
3
3
35
33
13
12
Total Liabilities
22
N/A
16
-27%
17
+9%
86
+392%
80
-6%
76
-5%
135
+77%
158
+17%
121
-23%
95
-22%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
47
49
51
50
47
50
63
109
181
223
Additional Paid In Capital
107
112
117
122
126
129
133
140
147
156
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
1
0
2
6
3
3
5
2
0
11
Total Equity
155
N/A
161
+4%
166
+3%
167
+0%
170
+2%
175
+3%
191
+9%
248
+30%
328
+33%
368
+12%
Total Liabilities & Equity
177
N/A
177
+0%
183
+4%
252
+37%
250
-1%
251
+1%
326
+29%
405
+25%
450
+11%
463
+3%
Shares Outstanding
Common Shares Outstanding
42
42
42
42
42
42
43
43
43
44

See Also

Summary
VIVO intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIVO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIVO stock valuation using valuation multiples.
Wall Street Estimates
VIVO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIVO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.